Lymphoma
Studies from College of Medicine yield new information about lymphoma
Published in Blood Weekly, September 10th, 2009
"The other had bilateral ischemic retinopathy, a relative contraindication to radiotherapy. Biopsies were performed 6 months after treatment. One patient had complete resolution of local disease, and the other had a partial response, remaining stable without signs of progression. During the 5 years of clinical follow-up, there was no evidence of systemic disease in either patient," wrote J.A. Sokol and colleagues, College of Medicine.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-09-10)
More Articles from Blood Weekly
- American Thoracic Society
Still holding their breath: Mortality on lung transplant wait list remains high for some - Dana-Farber Cancer Institute
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia - Research
Pass the prion: Inherited mutation leads to spontaneous prion infectivity - University Health Network
Night home hemodialysis shown to be as good as transplant in treating kidney failure - US Army Medical Research Institute of Infectious Diseases
Single host gene may hold key to treating both ebola and anthrax infections - Whitehead Institute for Biomedical Research
The ends of mRNAs may prevent the beginnings of cancer - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
